nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxycodone—Naltrexone—ABCB1—adrenal gland cancer	0.373	0.578	CrCbGaD
Oxycodone—Naloxone—ABCB1—adrenal gland cancer	0.272	0.422	CrCbGaD
Oxycodone—OPRD1—Peptide GPCRs—GNRHR—adrenal gland cancer	0.0218	0.0613	CbGpPWpGaD
Oxycodone—OPRK1—Peptide GPCRs—GNRHR—adrenal gland cancer	0.0191	0.0538	CbGpPWpGaD
Oxycodone—OPRM1—Peptide GPCRs—GNRHR—adrenal gland cancer	0.0162	0.0454	CbGpPWpGaD
Oxycodone—CYP2D6—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.0129	0.0363	CbGpPWpGaD
Oxycodone—OPRD1—Peptide GPCRs—TSHR—adrenal gland cancer	0.0116	0.0327	CbGpPWpGaD
Oxycodone—OPRK1—Peptide GPCRs—TSHR—adrenal gland cancer	0.0102	0.0287	CbGpPWpGaD
Oxycodone—OPRM1—Peptide GPCRs—TSHR—adrenal gland cancer	0.00863	0.0243	CbGpPWpGaD
Oxycodone—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.00844	0.0237	CbGpPWpGaD
Oxycodone—OPRM1—G-protein activation—POMC—adrenal gland cancer	0.00757	0.0213	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00688	0.0193	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00603	0.017	CbGpPWpGaD
Oxycodone—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00599	0.0168	CbGpPWpGaD
Oxycodone—OPRM1—Opioid Signalling—PRKACA—adrenal gland cancer	0.00576	0.0162	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00524	0.0147	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0051	0.0143	CbGpPWpGaD
Oxycodone—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.00462	0.013	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00459	0.0129	CbGpPWpGaD
Oxycodone—OPRM1—TCR Signaling Pathway—CDC42—adrenal gland cancer	0.00449	0.0126	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00412	0.0116	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00388	0.0109	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00367	0.0103	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00361	0.0102	CbGpPWpGaD
Oxycodone—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00344	0.00966	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00322	0.00905	CbGpPWpGaD
Oxycodone—OPRM1—Opioid Signalling—POMC—adrenal gland cancer	0.00314	0.00884	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00314	0.00882	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00305	0.00859	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00296	0.00832	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—TSHR—adrenal gland cancer	0.0028	0.00786	CbGpPWpGaD
Oxycodone—CYP3A7—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00279	0.00783	CbGpPWpGaD
Oxycodone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00278	0.00783	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00275	0.00774	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00272	0.00765	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00269	0.00756	CbGpPWpGaD
Oxycodone—OPRD1—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00269	0.00755	CbGpPWpGaD
Oxycodone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00265	0.00746	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.0026	0.0073	CbGpPWpGaD
Oxycodone—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00248	0.00699	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00245	0.0069	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00236	0.00663	CbGpPWpGaD
Oxycodone—OPRK1—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00236	0.00662	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00233	0.00654	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00219	0.00617	CbGpPWpGaD
Oxycodone—OPRD1—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.00214	0.00603	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00207	0.00583	CbGpPWpGaD
Oxycodone—CYP3A5—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00201	0.00566	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00199	0.0056	CbGpPWpGaD
Oxycodone—OPRM1—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00199	0.0056	CbGpPWpGaD
Oxycodone—OPRK1—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.00188	0.00529	CbGpPWpGaD
Oxycodone—OPRD1—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00181	0.00509	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00177	0.00499	CbGpPWpGaD
Oxycodone—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00177	0.00497	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00163	0.00457	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00161	0.00453	CbGpPWpGaD
Oxycodone—OPRM1—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.00159	0.00447	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00159	0.00446	CbGpPWpGaD
Oxycodone—OPRK1—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00159	0.00446	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00158	0.00444	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00155	0.00437	CbGpPWpGaD
Oxycodone—CYP3A7—Biological oxidations—POMC—adrenal gland cancer	0.00148	0.00416	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00148	0.00415	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00144	0.00404	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00144	0.00404	CbGpPWpGaD
Oxycodone—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00143	0.00403	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00143	0.00401	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00141	0.00397	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00139	0.00391	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00139	0.0039	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00139	0.0039	CbGpPWpGaD
Oxycodone—OPRM1—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00134	0.00377	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—SDHB—adrenal gland cancer	0.00132	0.00372	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00131	0.00369	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00129	0.00364	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00126	0.00355	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00126	0.00354	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00122	0.00342	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00121	0.00339	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00119	0.00336	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00118	0.00331	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00117	0.00329	CbGpPWpGaD
Oxycodone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00116	0.00325	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—POMC—adrenal gland cancer	0.0011	0.00308	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00109	0.00308	CbGpPWpGaD
Oxycodone—CYP3A5—Biological oxidations—POMC—adrenal gland cancer	0.00107	0.00301	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00107	0.003	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00106	0.00299	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00103	0.0029	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00103	0.00289	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000962	0.00271	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—POMC—adrenal gland cancer	0.00096	0.0027	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—SDHB—adrenal gland cancer	0.000957	0.00269	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000951	0.00267	CbGpPWpGaD
Oxycodone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000936	0.00263	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000919	0.00258	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000903	0.00254	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—CDC42—adrenal gland cancer	0.000874	0.00246	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SPRY2—adrenal gland cancer	0.00087	0.00245	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—SDHD—adrenal gland cancer	0.000853	0.0024	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—RRM1—adrenal gland cancer	0.000853	0.0024	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TSHR—adrenal gland cancer	0.000848	0.00238	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000844	0.00237	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—GNAS—adrenal gland cancer	0.000835	0.00235	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000834	0.00235	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—POMC—adrenal gland cancer	0.000812	0.00228	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000806	0.00227	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MEN1—adrenal gland cancer	0.000797	0.00224	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CDC42—adrenal gland cancer	0.000766	0.00215	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000763	0.00215	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000763	0.00214	CbGpPWpGaD
Oxycodone—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	0.000761	0.00214	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TSHR—adrenal gland cancer	0.000743	0.00209	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—GNAS—adrenal gland cancer	0.000732	0.00206	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000713	0.002	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000705	0.00198	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MEN1—adrenal gland cancer	0.000699	0.00197	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000681	0.00192	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—SDHB—adrenal gland cancer	0.00068	0.00191	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CDC42—adrenal gland cancer	0.000647	0.00182	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000645	0.00181	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—MED12—adrenal gland cancer	0.000636	0.00179	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TSHR—adrenal gland cancer	0.000628	0.00177	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000619	0.00174	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—GNAS—adrenal gland cancer	0.000619	0.00174	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—SDHD—adrenal gland cancer	0.000616	0.00173	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—RRM1—adrenal gland cancer	0.000616	0.00173	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000608	0.00171	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MEN1—adrenal gland cancer	0.000591	0.00166	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—POMC—adrenal gland cancer	0.000562	0.00158	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000543	0.00153	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000534	0.0015	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CDC42—adrenal gland cancer	0.000516	0.00145	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IGF2—adrenal gland cancer	0.000497	0.0014	CbGpPWpGaD
Oxycodone—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.000497	0.0014	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—GNAS—adrenal gland cancer	0.000493	0.00139	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—POMC—adrenal gland cancer	0.000493	0.00139	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000481	0.00135	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PRKACA—adrenal gland cancer	0.000464	0.0013	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—MED12—adrenal gland cancer	0.00046	0.00129	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000459	0.00129	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CDC42—adrenal gland cancer	0.000453	0.00127	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000451	0.00127	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.000445	0.00125	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—RRM1—adrenal gland cancer	0.000438	0.00123	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—SDHD—adrenal gland cancer	0.000438	0.00123	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IGF2—adrenal gland cancer	0.000436	0.00123	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—GNAS—adrenal gland cancer	0.000432	0.00122	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000422	0.00119	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—POMC—adrenal gland cancer	0.000417	0.00117	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TERT—adrenal gland cancer	0.000414	0.00116	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CDC42—adrenal gland cancer	0.000382	0.00108	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GNAS—adrenal gland cancer	0.000376	0.00106	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ABCB1—adrenal gland cancer	0.000369	0.00104	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IGF2—adrenal gland cancer	0.000369	0.00104	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—GNAS—adrenal gland cancer	0.000365	0.00103	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TERT—adrenal gland cancer	0.000363	0.00102	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—BAD—adrenal gland cancer	0.00036	0.00101	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000356	0.001	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	0.000335	0.000943	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—POMC—adrenal gland cancer	0.000332	0.000934	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—BRAF—adrenal gland cancer	0.000328	0.000922	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—MED12—adrenal gland cancer	0.000327	0.000919	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000318	0.000894	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—BAD—adrenal gland cancer	0.000316	0.000888	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TERT—adrenal gland cancer	0.000307	0.000863	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—POMC—adrenal gland cancer	0.000291	0.000819	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—BRAF—adrenal gland cancer	0.000288	0.000808	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000287	0.000806	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000287	0.000806	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000279	0.000784	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GNAS—adrenal gland cancer	0.000272	0.000764	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—BAD—adrenal gland cancer	0.000267	0.000751	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	0.000267	0.00075	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—POMC—adrenal gland cancer	0.000253	0.000712	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—POMC—adrenal gland cancer	0.000246	0.000692	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—BRAF—adrenal gland cancer	0.000243	0.000683	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	0.000238	0.00067	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000237	0.000666	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000236	0.000662	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000214	0.000601	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000208	0.000584	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PTGS2—adrenal gland cancer	0.000202	0.000568	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GNAS—adrenal gland cancer	0.000193	0.000543	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	0.00019	0.000533	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—EGFR—adrenal gland cancer	0.000188	0.000528	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—POMC—adrenal gland cancer	0.000183	0.000514	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000176	0.000494	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—EGFR—adrenal gland cancer	0.000165	0.000463	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TP53—adrenal gland cancer	0.000158	0.000443	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	0.000156	0.000438	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	0.000146	0.00041	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—EGFR—adrenal gland cancer	0.000139	0.000391	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TP53—adrenal gland cancer	0.000138	0.000389	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—POMC—adrenal gland cancer	0.00013	0.000366	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GNAS—adrenal gland cancer	0.000126	0.000355	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	0.000124	0.000349	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TP53—adrenal gland cancer	0.000117	0.000328	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	0.000104	0.000292	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—POMC—adrenal gland cancer	8.51e-05	0.000239	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	6.78e-05	0.000191	CbGpPWpGaD
